LANSOPRAZOLE

LANSOPRAZOLE was reported 179034 times

LANSOPRAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RENAL HAEMANGIOMA 790 0.9912
1 APPENDICOLITH 304 0.7855
2 CARDIOSPASM 409 0.7330
3 SLEEP DISORDER THERAPY 132 0.6667
4 HYPERTENSIVE NEPHROPATHY 671 0.6289
5 IMMUNISATION 263 0.6060
6 REBOUND ACID HYPERSECRETION 1719 0.5677
7 GRIP STRENGTH 129 0.5633
8 PALMOPLANTAR KERATODERMA 398 0.5490
9 END STAGE RENAL DISEASE 9804 0.5370
10 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 542 0.5104
11 NEPHROGENIC ANAEMIA 2214 0.4775
12 SWOLLEN JOINT COUNT 113 0.4520
13 CHRONIC KIDNEY DISEASE 32796 0.4312
14 ANALGESIC THERAPY 134 0.4174
15 DEEP VEIN THROMBOSIS POSTOPERATIVE 762 0.3804
16 LUPUS VULGARIS 464 0.3683
17 HYPERPARATHYROIDISM SECONDARY 912 0.3636
18 C-REACTIVE PROTEIN 334 0.3603
19 DRUG THERAPY 120 0.3540
20 HYPERCHLORHYDRIA 2028 0.3443
21 RENAL INJURY 9521 0.3202
22 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 176 0.3137
23 DIABETIC NEPHROPATHY 662 0.3005
24 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 595 0.2869
25 X-RAY ABNORMAL 497 0.2777
26 SWOLLEN JOINT COUNT INCREASED 841 0.2635
27 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 171 0.2560
28 NEPHROSCLEROSIS 284 0.2556
29 DISLOCATION OF VERTEBRA 537 0.2352
30 FACET JOINT SYNDROME 735 0.2255
31 TUBULOINTERSTITIAL NEPHRITIS 4194 0.2235
32 RHEUMATIC FEVER 947 0.2122
33 ATRIAL TACHYCARDIA 440 0.2093
34 DUODENAL ULCER PERFORATION 1368 0.1838
35 PRURITUS GENITAL 431 0.1829
36 RHEUMATOID FACTOR POSITIVE 1036 0.1792
37 PORPHYRIA ACUTE 257 0.1791
38 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 163 0.1758
39 CATARRH 156 0.1726
40 PERIPHERAL VENOUS DISEASE 699 0.1710
41 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1221 0.1702
42 RETINITIS 292 0.1689
43 RENAL ATROPHY 203 0.1625
44 STEROID DEPENDENCE 138 0.1572
45 MUSCLE INJURY 1263 0.1523
46 NEPHROPATHY 1411 0.1510
47 C-REACTIVE PROTEIN ABNORMAL 916 0.1427
48 REBOUND EFFECT 1585 0.1401
49 ELECTRIC SHOCK 120 0.1400
50 HELICOBACTER INFECTION 1423 0.1383
51 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 842 0.1295
52 ACUTE KIDNEY INJURY 18838 0.1230
53 FOLLICULITIS 1282 0.1221
54 COLITIS MICROSCOPIC 569 0.1200
55 CAROTID ARTERY OCCLUSION 428 0.1172
56 TOTAL LUNG CAPACITY DECREASED 184 0.1151
57 RENAL ARTERY STENOSIS 155 0.1124
58 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 197 0.1107
59 TENSION HEADACHE 474 0.1101
60 PERICARDITIS 1827 0.1086
61 PEMPHIGUS 1344 0.1074
62 RENAL FAILURE 13850 0.1042
63 HAND DEFORMITY 1366 0.1040
64 LIP DRY 941 0.1035
65 SLEEP TERROR 425 0.1008
66 CALCIUM DEFICIENCY 129 0.0995
67 HYPERPHOSPHATAEMIA 210 0.0976
68 BONE EROSION 331 0.0935
69 ESSENTIAL HYPERTENSION 170 0.0928
70 DIALYSIS 1276 0.0898
71 BREAST CANCER STAGE III 581 0.0896
72 BURSITIS 1066 0.0878
73 INTERVERTEBRAL DISCITIS 165 0.0874
74 RENAL CYST 694 0.0873
75 LUNG OPACITY 224 0.0849
76 BLOOD PHOSPHORUS INCREASED 228 0.0834
77 DRUG TOLERANCE DECREASED 230 0.0818
78 AUTOIMMUNE DISORDER 791 0.0811
79 BURNS SECOND DEGREE 141 0.0803
80 WOUND INFECTION 864 0.0788
81 JOINT RANGE OF MOTION DECREASED 1050 0.0782
82 HYPERCHOLESTEROLAEMIA 744 0.0770
83 SYNOVITIS 1363 0.0755
84 PLEURITIC PAIN 205 0.0742
85 IRRITABLE BOWEL SYNDROME 1495 0.0697
86 BRONCHIECTASIS 461 0.0684
87 NEUTROPENIC SEPSIS 472 0.0660
88 GLOSSODYNIA 1467 0.0655
89 RENAL MASS 129 0.0626
90 GASTRIC POLYPS 141 0.0624
91 MATERNAL EXPOSURE TIMING UNSPECIFIED 234 0.0622
92 LOWER RESPIRATORY TRACT INFECTION 2766 0.0608
93 SUBARACHNOID HAEMORRHAGE 606 0.0594
94 OBESITY 945 0.0593
95 GRIP STRENGTH DECREASED 521 0.0591
96 LIVE BIRTH 493 0.0589
97 HYPOMAGNESAEMIA 813 0.0583
98 FACIAL PAIN 519 0.0581
99 FIBROMYALGIA 1410 0.0579
100 AZOTAEMIA 229 0.0573
101 PULMONARY FIBROSIS 1092 0.0569
102 PUSTULAR PSORIASIS 195 0.0567
103 TYPE 2 DIABETES MELLITUS 1863 0.0553
104 LIVER INJURY 1349 0.0549
105 GASTROOESOPHAGEAL REFLUX DISEASE 4334 0.0538
106 WOUND 1502 0.0537
107 BLOOD URIC ACID INCREASED 309 0.0535
108 LOWER LIMB FRACTURE 1022 0.0531
109 RASH VESICULAR 256 0.0529
110 EOSINOPHIL COUNT DECREASED 125 0.0525
111 IRON DEFICIENCY 231 0.0513
112 MIXED LIVER INJURY 154 0.0511
113 SCIATICA 814 0.0510
114 WALKING AID USER 329 0.0498
115 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 246 0.0485
116 HYPOPNOEA 168 0.0484
117 VASCULITIS 560 0.0480
118 SYSTEMIC LUPUS ERYTHEMATOSUS 1704 0.0480
119 AORTIC STENOSIS 167 0.0479
120 EYE INJURY 145 0.0477
121 APLASTIC ANAEMIA 246 0.0471
122 GLOMERULONEPHRITIS 114 0.0465
123 PROTEINURIA 883 0.0464
124 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 252 0.0463
125 HYPOPHOSPHATAEMIA 341 0.0461
126 RENAL TRANSPLANT 165 0.0456
127 HYPONATRAEMIA 2571 0.0456
128 EXOSTOSIS 416 0.0455
129 RENAL TUBULAR NECROSIS 443 0.0451
130 HYDRONEPHROSIS 334 0.0446
131 IMPAIRED HEALING 1429 0.0435
132 APPENDICITIS 403 0.0431
133 WRONG PATIENT RECEIVED PRODUCT 126 0.0430
134 BLEPHAROSPASM 269 0.0427
135 PRESCRIBED OVERDOSE 825 0.0426
136 ULCER HAEMORRHAGE 288 0.0425
137 VENTRICULAR FIBRILLATION 465 0.0418
138 ALCOHOL POISONING 112 0.0418
139 DEMYELINATION 170 0.0414
140 HAEMODIALYSIS 348 0.0414
141 BLOOD CHOLESTEROL INCREASED 1914 0.0410
142 CARDIAC MURMUR 354 0.0409
143 CHOLECYSTITIS CHRONIC 271 0.0404
144 VENTRICULAR TACHYCARDIA 668 0.0404
145 COMA SCALE ABNORMAL 117 0.0403
146 NOCTURIA 485 0.0399
147 LUPUS-LIKE SYNDROME 359 0.0395
148 BREAST CANCER STAGE II 326 0.0391
149 OSTEOARTHRITIS 1636 0.0386
150 RALES 224 0.0385
151 RENAL IMPAIRMENT 3207 0.0381
152 NAIL DISORDER 331 0.0378
153 HEPATIC CYTOLYSIS 481 0.0377
154 PEPTIC ULCER 125 0.0376
155 MYOSITIS 335 0.0373
156 RED BLOOD CELL SEDIMENTATION RATE INCREASED 413 0.0373
157 VITAMIN B12 DEFICIENCY 150 0.0370
158 HYPERLIPIDAEMIA 440 0.0368
159 HIATUS HERNIA 469 0.0362
160 WHEEZING 2125 0.0358
161 IRON DEFICIENCY ANAEMIA 330 0.0357
162 CHOLECYSTITIS ACUTE 202 0.0356
163 MYASTHENIA GRAVIS 287 0.0355
164 AGRANULOCYTOSIS 647 0.0348
165 VITAMIN D DEFICIENCY 339 0.0347
166 PSORIATIC ARTHROPATHY 1397 0.0344
167 OESOPHAGITIS 376 0.0344
168 CAROTID ARTERY STENOSIS 119 0.0340
169 PYELONEPHRITIS 288 0.0332
170 NIGHT SWEATS 1066 0.0331
171 DIABETIC NEUROPATHY 163 0.0329
172 JAUNDICE CHOLESTATIC 116 0.0328
173 ADRENAL INSUFFICIENCY 398 0.0328
174 OEDEMA 1773 0.0327
175 PAROSMIA 246 0.0326
176 LIP SWELLING 1080 0.0324
177 LIVER DISORDER 1438 0.0324
178 MUSCLE TWITCHING 743 0.0322
179 ANOSMIA 465 0.0321
180 ARTHROPATHY 1782 0.0320
181 SWOLLEN TONGUE 1000 0.0320
182 DELIRIUM 1109 0.0319
183 GINGIVAL PAIN 254 0.0319
184 POST-TRAUMATIC STRESS DISORDER 212 0.0316
185 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 324 0.0315
186 RHINITIS 254 0.0315
187 ASPIRATION 345 0.0315
188 CHRONIC SINUSITIS 118 0.0314
189 HYPERURICAEMIA 129 0.0314
190 CONTRAINDICATED PRODUCT ADMINISTERED 944 0.0311
191 MUSCULOSKELETAL PAIN 1629 0.0311
192 TRANSIENT ISCHAEMIC ATTACK 1039 0.0308
193 FOOT DEFORMITY 341 0.0307
194 OBSTRUCTIVE AIRWAYS DISORDER 342 0.0307
195 MELAENA 675 0.0306
196 CANDIDIASIS 123 0.0306
197 NEPHROTIC SYNDROME 210 0.0306
198 ANGIOEDEMA 1351 0.0305
199 RECTAL HAEMORRHAGE 1307 0.0304
200 GASTRITIS 800 0.0304
201 HAEMATURIA 1039 0.0303
202 HYPOCALCAEMIA 574 0.0303
203 SPINAL OSTEOARTHRITIS 266 0.0302
204 ULCER 481 0.0302
205 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 518 0.0302
206 BLISTER 1696 0.0302
207 CARDIOGENIC SHOCK 433 0.0301
208 HIP ARTHROPLASTY 462 0.0301
209 TOXIC EPIDERMAL NECROLYSIS 458 0.0301
210 CHOLESTASIS 579 0.0301
211 BLOOD ALBUMIN DECREASED 239 0.0301
212 ORTHOSTATIC HYPOTENSION 524 0.0301
213 GASTRITIS EROSIVE 140 0.0300
214 GINGIVAL DISORDER 114 0.0296
215 INTERVERTEBRAL DISC DEGENERATION 274 0.0296
216 INTESTINAL ISCHAEMIA 162 0.0294
217 DYSLIPIDAEMIA 149 0.0293
218 FEMORAL NECK FRACTURE 150 0.0292
219 JOINT DISLOCATION 309 0.0292
220 INFUSION RELATED REACTION 1935 0.0292
221 INCORRECT PRODUCT ADMINISTRATION DURATION 630 0.0291
222 EOSINOPHILIA 508 0.0290
223 STOMATITIS 1758 0.0290
224 URINE OUTPUT DECREASED 253 0.0289
225 HEPATIC CIRRHOSIS 541 0.0288
226 LUNG DISORDER 1410 0.0287
227 GAIT INABILITY 960 0.0287
228 LIVER FUNCTION TEST ABNORMAL 833 0.0286
229 SPUTUM DISCOLOURED 271 0.0285
230 HYPERKALAEMIA 998 0.0284
231 BLOOD PRESSURE DIASTOLIC DECREASED 210 0.0284
232 RENAL FAILURE CHRONIC 218 0.0283
233 POLYP 185 0.0282
234 HYPOKALAEMIA 1302 0.0282
235 OSTEOPOROSIS 1159 0.0281
236 POLYURIA 230 0.0281
237 CORONARY ARTERY DISEASE 850 0.0280
238 DYSURIA 1032 0.0280
239 PURPURA 248 0.0280
240 HAEMATEMESIS 710 0.0280
241 DIVERTICULUM 199 0.0280
242 BLOOD CALCIUM INCREASED 245 0.0279
243 INTERSTITIAL LUNG DISEASE 1350 0.0279
244 LEFT VENTRICULAR DYSFUNCTION 186 0.0277
245 AORTIC VALVE INCOMPETENCE 118 0.0277
246 LEFT VENTRICULAR HYPERTROPHY 118 0.0275
247 MICTURITION URGENCY 313 0.0274
248 HEPATITIS CHOLESTATIC 164 0.0272
249 BLOOD UREA INCREASED 452 0.0270
250 MYOCARDIAL ISCHAEMIA 306 0.0269
251 NEUTROPHIL COUNT INCREASED 275 0.0268
252 DISCOMFORT 1636 0.0268
253 TRICUSPID VALVE INCOMPETENCE 213 0.0268
254 MITRAL VALVE INCOMPETENCE 303 0.0267
255 ATELECTASIS 258 0.0267
256 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 220 0.0267
257 BENIGN PROSTATIC HYPERPLASIA 137 0.0265
258 UPPER GASTROINTESTINAL HAEMORRHAGE 445 0.0264
259 C-REACTIVE PROTEIN INCREASED 960 0.0264
260 ROAD TRAFFIC ACCIDENT 1102 0.0263
261 DIPLOPIA 680 0.0262
262 MULTIPLE ORGAN DYSFUNCTION SYNDROME 741 0.0261
263 ABNORMAL LOSS OF WEIGHT 178 0.0261
264 DUODENAL ULCER 184 0.0261
265 ARTERIOSCLEROSIS CORONARY ARTERY 172 0.0259
266 GASTRIC ULCER 493 0.0259
267 AMNESIA 1674 0.0257
268 HEPATIC ENZYME INCREASED 1754 0.0257
269 CLOSTRIDIUM DIFFICILE COLITIS 272 0.0256
270 COORDINATION ABNORMAL 357 0.0256
271 INJURY 1798 0.0256
272 DRY MOUTH 2073 0.0255
273 DYSPEPSIA 2513 0.0255
274 CYSTIC FIBROSIS 141 0.0254
275 CARDIOMEGALY 312 0.0253
276 CONFUSIONAL STATE 4093 0.0253
277 PNEUMONIA BACTERIAL 232 0.0253
278 BLOOD ALKALINE PHOSPHATASE INCREASED 626 0.0252
279 ENTEROCOLITIS 145 0.0251
280 KIDNEY INFECTION 490 0.0249
281 PEMPHIGOID 187 0.0248
282 PRESCRIBED UNDERDOSE 492 0.0246
283 TROPONIN INCREASED 187 0.0246
284 CHOLANGITIS 152 0.0245
285 INTERNATIONAL NORMALISED RATIO INCREASED 698 0.0245
286 HYPOALBUMINAEMIA 190 0.0244
287 PNEUMONIA ASPIRATION 610 0.0244
288 BLOOD PRESSURE SYSTOLIC DECREASED 111 0.0244
289 TOXIC SKIN ERUPTION 245 0.0243
290 SUBDURAL HAEMATOMA 348 0.0243
291 HEPATITIS ACUTE 157 0.0241
292 CHEST PAIN 4444 0.0240
293 ASCITES 704 0.0239
294 RENAL FAILURE ACUTE 1015 0.0239
295 BLOOD MAGNESIUM DECREASED 206 0.0238
296 HUMERUS FRACTURE 115 0.0238
297 ACUTE CORONARY SYNDROME 197 0.0238
298 CIRCULATORY COLLAPSE 405 0.0238
299 BLOOD TEST ABNORMAL 334 0.0237
300 PHARYNGOLARYNGEAL PAIN 126 0.0237
301 HEPATOCELLULAR INJURY 336 0.0237
302 SWELLING 2213 0.0236
303 HYPOVOLAEMIA 138 0.0236
304 CEREBRAL INFARCTION 574 0.0235
305 PERIPHERAL VASCULAR DISORDER 121 0.0235
306 HYPERNATRAEMIA 117 0.0235
307 MUSCULOSKELETAL STIFFNESS 2048 0.0234
308 PROTHROMBIN TIME PROLONGED 139 0.0232
309 PANCREATITIS ACUTE 520 0.0231
310 HAEMOPTYSIS 642 0.0230
311 DISSEMINATED INTRAVASCULAR COAGULATION 324 0.0230
312 FAECALOMA 126 0.0230
313 RASH MACULO-PAPULAR 509 0.0229
314 CORONARY ARTERY STENOSIS 115 0.0228
315 ARTERIOSCLEROSIS 215 0.0228
316 ANGINA UNSTABLE 148 0.0227
317 NEPHROLITHIASIS 1044 0.0227
318 MOUTH ULCERATION 478 0.0227
319 OEDEMA PERIPHERAL 2763 0.0226
320 FREQUENT BOWEL MOVEMENTS 612 0.0226
321 CROHN'S DISEASE 155 0.0226
322 KNEE ARTHROPLASTY 475 0.0225
323 GASTROINTESTINAL MOTILITY DISORDER 120 0.0224
324 BLOOD CALCIUM DECREASED 252 0.0224
325 TINNITUS 1028 0.0224
326 ELECTROCARDIOGRAM ABNORMAL 173 0.0220
327 ORAL CANDIDIASIS 289 0.0219
328 FULL BLOOD COUNT ABNORMAL 232 0.0219
329 SINUS BRADYCARDIA 212 0.0219
330 JAUNDICE 588 0.0218
331 INFLAMMATION 1126 0.0218
332 GENERAL PHYSICAL HEALTH DETERIORATION 2521 0.0218
333 GASTROENTERITIS 317 0.0217
334 MOBILITY DECREASED 1560 0.0217
335 CONTUSION 2085 0.0216
336 BONE DISORDER 394 0.0216
337 ANOREXIA 277 0.0215
338 GENERAL SYMPTOM 161 0.0215
339 UROSEPSIS 198 0.0214
340 WHITE BLOOD CELL COUNT INCREASED 823 0.0214
341 RENAL DISORDER 999 0.0214
342 CHOLECYSTITIS 255 0.0214
343 BLOOD CREATININE INCREASED 1392 0.0213
344 ANGIOPATHY 119 0.0212
345 HEPATIC FUNCTION ABNORMAL 791 0.0212
346 RASH PAPULAR 475 0.0212
347 SPINAL COMPRESSION FRACTURE 175 0.0211
348 ERYTHEMA MULTIFORME 197 0.0211
349 OLIGURIA 131 0.0211
350 BACK DISORDER 343 0.0211
351 JOINT SWELLING 2538 0.0210
352 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 541 0.0210
353 THERAPY NON-RESPONDER 942 0.0209
354 SLEEP DISORDER 1478 0.0209
355 ASTHMA 2366 0.0209
356 CHOLELITHIASIS 686 0.0209
357 DRUG ERUPTION 370 0.0209
358 FEBRILE NEUTROPENIA 1381 0.0208
359 HYPERGLYCAEMIA 756 0.0207
360 ELECTROCARDIOGRAM QT PROLONGED 746 0.0207
361 EOSINOPHIL COUNT INCREASED 172 0.0206
362 MUCOSAL INFLAMMATION 540 0.0206
363 MALNUTRITION 230 0.0205
364 LIVER FUNCTION TEST INCREASED 441 0.0205
365 RESPIRATORY DISORDER 611 0.0204
366 ABDOMINAL PAIN UPPER 4196 0.0204
367 TENDERNESS 212 0.0203
368 HYPERTRANSAMINASAEMIA 141 0.0203
369 URINARY RETENTION 674 0.0202
370 PREGNANCY 404 0.0202
371 CARDIAC FAILURE ACUTE 134 0.0201
372 MIGRAINE 1916 0.0201
373 TYPE 1 DIABETES MELLITUS 120 0.0199
374 RHEUMATOID ARTHRITIS 2262 0.0199
375 HEPATIC STEATOSIS 371 0.0199
376 EAR PAIN 387 0.0199
377 FAECES DISCOLOURED 431 0.0199
378 ACUTE MYOCARDIAL INFARCTION 585 0.0198
379 OSTEOPENIA 300 0.0197
380 HYPOXIA 696 0.0197
381 ANGINA PECTORIS 566 0.0197
382 PULMONARY MASS 294 0.0197
383 ABDOMINAL DISCOMFORT 3309 0.0197
384 ARTHRITIS 1551 0.0197
385 EAR INFECTION 524 0.0197
386 WEIGHT FLUCTUATION 206 0.0197
387 PNEUMOCYSTIS JIROVECII PNEUMONIA 197 0.0196
388 ABDOMINAL PAIN 4562 0.0196
389 MEDICATION ERROR 1089 0.0196
390 BLOOD SODIUM DECREASED 369 0.0196
391 DRUG INTERACTION 3104 0.0195
392 DRUG INTOLERANCE 1869 0.0193
393 GALLBLADDER DISORDER 345 0.0193
394 GASTROINTESTINAL DISORDER 1730 0.0193
395 HEPATIC ENCEPHALOPATHY 179 0.0192
396 SINUSITIS 1965 0.0192
397 PLEURAL EFFUSION 1160 0.0190
398 INCORRECT DRUG ADMINISTRATION DURATION 535 0.0190
399 LUNG INFILTRATION 168 0.0190
400 RENAL PAIN 201 0.0189
401 ODYNOPHAGIA 113 0.0189
402 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 987 0.0189
403 COLITIS ISCHAEMIC 127 0.0188
404 HAEMORRHOIDS 367 0.0188
405 NEUTROPHIL COUNT DECREASED 766 0.0188
406 DEHYDRATION 2503 0.0187
407 PAIN OF SKIN 503 0.0187
408 URINARY INCONTINENCE 553 0.0186
409 ILL-DEFINED DISORDER 1133 0.0186
410 INTENTIONAL PRODUCT USE ISSUE 1631 0.0186
411 BACTERIAL INFECTION 347 0.0186
412 ELECTROLYTE IMBALANCE 216 0.0186
413 PANCYTOPENIA 1039 0.0186
414 HALLUCINATION 1400 0.0186
415 SCOLIOSIS 115 0.0185
416 SHOCK HAEMORRHAGIC 151 0.0185
417 CLOSTRIDIUM DIFFICILE INFECTION 404 0.0185
418 COGNITIVE DISORDER 864 0.0185
419 FLANK PAIN 173 0.0184
420 BRADYCARDIA 973 0.0183
421 ALANINE AMINOTRANSFERASE INCREASED 1125 0.0183
422 SEPSIS 2040 0.0183
423 RESPIRATORY RATE INCREASED 162 0.0182
424 PANCREATITIS 964 0.0182
425 ECONOMIC PROBLEM 276 0.0182
426 ACUTE RESPIRATORY FAILURE 350 0.0182
427 SOPOR 241 0.0182
428 ABNORMAL FAECES 149 0.0182
429 SWELLING FACE 1184 0.0182
430 TEMPERATURE INTOLERANCE 187 0.0181
431 LYMPHOCYTE COUNT DECREASED 320 0.0181
432 GOUT 324 0.0180
433 POLLAKIURIA 751 0.0180
434 ESCHERICHIA INFECTION 148 0.0180
435 SUPRAVENTRICULAR TACHYCARDIA 172 0.0179
436 DERMATITIS BULLOUS 130 0.0179
437 MUSCULAR WEAKNESS 2035 0.0179
438 LYMPHOPENIA 253 0.0179
439 EMPHYSEMA 180 0.0178
440 GAMMA-GLUTAMYLTRANSFERASE INCREASED 394 0.0178
441 ACUTE RESPIRATORY DISTRESS SYNDROME 314 0.0177
442 CELLULITIS 891 0.0177
443 HYPERTENSION 3741 0.0176
444 PERIPHERAL SWELLING 2716 0.0176
445 ATRIOVENTRICULAR BLOCK COMPLETE 118 0.0176
446 EPILEPSY 536 0.0175
447 THERAPEUTIC PRODUCT EFFECT DECREASED 781 0.0174
448 PULMONARY HYPERTENSION 363 0.0174
449 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 154 0.0174
450 HEMIPARESIS 295 0.0174
451 MULTIPLE FRACTURES 286 0.0174
452 HAEMATOCRIT DECREASED 345 0.0174
453 SLEEP APNOEA SYNDROME 331 0.0173
454 DIABETES MELLITUS 1318 0.0173
455 PALPITATIONS 2024 0.0173
456 PSEUDOMONAS INFECTION 148 0.0172
457 RHABDOMYOLYSIS 719 0.0172
458 JOINT STIFFNESS 452 0.0172
459 ALTERED STATE OF CONSCIOUSNESS 373 0.0172
460 NEURALGIA 418 0.0172
461 CHROMATURIA 387 0.0171
462 ANAEMIA 3269 0.0171
463 LARGE INTESTINE PERFORATION 119 0.0171
464 NIGHTMARE 593 0.0171
465 MUSCULOSKELETAL CHEST PAIN 265 0.0171
466 BACK INJURY 186 0.0171
467 HEPATITIS 437 0.0171
468 UPPER RESPIRATORY TRACT INFECTION 788 0.0170
469 ROTATOR CUFF SYNDROME 219 0.0170
470 DRUG-INDUCED LIVER INJURY 532 0.0169
471 TORSADE DE POINTES 133 0.0169
472 ILEUS 210 0.0169
473 AUTOIMMUNE HEPATITIS 117 0.0168
474 ATRIAL FLUTTER 134 0.0168
475 ATAXIA 199 0.0168
476 URTICARIA 2806 0.0167
477 MUSCLE ATROPHY 212 0.0167
478 CARPAL TUNNEL SYNDROME 234 0.0167
479 JOINT EFFUSION 115 0.0167
480 PYREXIA 5765 0.0166
481 PULMONARY EMBOLISM 1577 0.0166
482 ABDOMINAL DISTENSION 1728 0.0165
483 NECK PAIN 924 0.0165
484 TACHYCARDIA 1465 0.0165
485 BLOOD CREATINE PHOSPHOKINASE INCREASED 473 0.0164
486 FOOT FRACTURE 311 0.0164
487 BLOOD POTASSIUM DECREASED 493 0.0164
488 COAGULOPATHY 273 0.0164
489 SPINAL DISORDER 155 0.0164
490 HYPOGLYCAEMIA 792 0.0163
491 DEPRESSION 3712 0.0163
492 PHARYNGITIS 202 0.0163
493 DEEP VEIN THROMBOSIS 1057 0.0162
494 BRONCHOPULMONARY ASPERGILLOSIS 126 0.0162
495 CARDIOMYOPATHY 240 0.0162
496 THROMBOCYTOPENIA 1815 0.0162
497 DECUBITUS ULCER 132 0.0162
498 ECCHYMOSIS 111 0.0162
499 FACE OEDEMA 273 0.0162
500 ATRIOVENTRICULAR BLOCK 125 0.0162
501 ORAL PAIN 362 0.0162
502 LETHARGY 929 0.0161
503 HYPERCALCAEMIA 199 0.0161
504 ASPARTATE AMINOTRANSFERASE INCREASED 856 0.0161
505 MYOCLONUS 192 0.0161
506 ATRIAL FIBRILLATION 1567 0.0161
507 PARAESTHESIA ORAL 232 0.0161
508 EYE PRURITUS 540 0.0161
509 INFECTION 2324 0.0160
510 BLOOD TRIGLYCERIDES INCREASED 283 0.0160
511 SMALL INTESTINAL OBSTRUCTION 197 0.0160
512 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 271 0.0159
513 BLOOD PRESSURE SYSTOLIC INCREASED 311 0.0159
514 TENDONITIS 246 0.0159
515 TASTE DISORDER 322 0.0159
516 BLOOD LACTATE DEHYDROGENASE INCREASED 251 0.0158
517 INCONTINENCE 167 0.0158
518 VOMITING 7418 0.0158
519 BLOOD BILIRUBIN INCREASED 426 0.0158
520 BLOOD POTASSIUM INCREASED 256 0.0158
521 DIABETES MELLITUS INADEQUATE CONTROL 279 0.0157
522 DECREASED APPETITE 3635 0.0156
523 SINUS TACHYCARDIA 222 0.0156
524 RIB FRACTURE 321 0.0156
525 HICCUPS 128 0.0156
526 DISTURBANCE IN ATTENTION 841 0.0156
527 RESPIRATORY FAILURE 1135 0.0155
528 MYOPATHY 134 0.0155
529 CORONARY ARTERY OCCLUSION 211 0.0154
530 DYSPHAGIA 1454 0.0153
531 GASTRIC CANCER 388 0.0153
532 LOWER GASTROINTESTINAL HAEMORRHAGE 113 0.0153
533 PULMONARY CONGESTION 201 0.0152
534 HYPOAESTHESIA 2273 0.0152
535 SEPTIC SHOCK 660 0.0152
536 MOUTH HAEMORRHAGE 111 0.0151
537 BODY TEMPERATURE DECREASED 149 0.0151
538 ISCHAEMIC STROKE 270 0.0151
539 HYPERBILIRUBINAEMIA 156 0.0150
540 HYPOPHAGIA 384 0.0150
541 GASTROINTESTINAL PAIN 165 0.0150
542 CONGENITAL ANOMALY 116 0.0150
543 SYNCOPE 1499 0.0150
544 MATERNAL EXPOSURE DURING PREGNANCY 1333 0.0149
545 COLITIS ULCERATIVE 668 0.0149
546 DYSPNOEA 8400 0.0148
547 PNEUMONITIS 404 0.0148
548 HYPOTHYROIDISM 472 0.0148
549 THROMBOTIC MICROANGIOPATHY 144 0.0148
550 INTERVERTEBRAL DISC PROTRUSION 323 0.0148
551 DYSPNOEA EXERTIONAL 556 0.0147
552 ANAPHYLACTIC REACTION 814 0.0147
553 METABOLIC ACIDOSIS 471 0.0147
554 CONDITION AGGRAVATED 4477 0.0147
555 SALIVARY HYPERSECRETION 147 0.0147
556 EJECTION FRACTION DECREASED 228 0.0147
557 ACIDOSIS 112 0.0146
558 CARDIAC FAILURE 1176 0.0146
559 MUSCLE SPASMS 2688 0.0146
560 IMPAIRED GASTRIC EMPTYING 199 0.0146
561 CONSTIPATION 3167 0.0145
562 DIVERTICULITIS 402 0.0145
563 PERICARDIAL EFFUSION 335 0.0145
564 GASTROINTESTINAL HAEMORRHAGE 1208 0.0144
565 ANAL INCONTINENCE 130 0.0144
566 PARAESTHESIA 2273 0.0144
567 HAEMOGLOBIN DECREASED 1481 0.0144
568 NEUROPATHY PERIPHERAL 1371 0.0144
569 GLOMERULAR FILTRATION RATE DECREASED 177 0.0144
570 HYPERSENSITIVITY 2673 0.0144
571 DYSARTHRIA 542 0.0144
572 STEVENS-JOHNSON SYNDROME 320 0.0144
573 MULTI-ORGAN FAILURE 248 0.0143
574 OXYGEN SATURATION DECREASED 806 0.0143
575 TRANSFUSION 150 0.0143
576 BODY TEMPERATURE INCREASED 292 0.0143
577 DIARRHOEA 9234 0.0143
578 PNEUMONIA 4625 0.0143
579 COLITIS 540 0.0142
580 ANXIETY 4052 0.0142
581 TRANSAMINASES INCREASED 316 0.0142
582 HEART RATE INCREASED 1407 0.0142
583 OSTEOMYELITIS 257 0.0142
584 HYPERHIDROSIS 1827 0.0142
585 DISABILITY 279 0.0141
586 MUSCLE STRAIN 122 0.0141
587 BLINDNESS 573 0.0140
588 VENTRICULAR EXTRASYSTOLES 146 0.0140
589 PHARYNGEAL OEDEMA 216 0.0140
590 PRESYNCOPE 341 0.0140
591 BONE MARROW FAILURE 285 0.0140
592 MALAISE 6131 0.0140
593 COLD SWEAT 246 0.0139
594 TOOTH ABSCESS 142 0.0139
595 BRONCHITIS 1032 0.0139
596 BACK PAIN 3228 0.0139
597 ALOPECIA 2722 0.0138
598 MEMORY IMPAIRMENT 1904 0.0138
599 DEPRESSED LEVEL OF CONSCIOUSNESS 547 0.0138
600 CARDIAC FAILURE CONGESTIVE 1109 0.0138
601 RESTLESS LEGS SYNDROME 251 0.0138
602 ERUCTATION 267 0.0138
603 OSTEONECROSIS OF JAW 340 0.0137
604 SUDDEN DEATH 145 0.0137
605 STAPHYLOCOCCAL INFECTION 452 0.0137
606 ANKLE FRACTURE 212 0.0137
607 DYSPHONIA 801 0.0137
608 HAEMATOMA 354 0.0136
609 DENTAL CARIES 151 0.0136
610 BACTERAEMIA 162 0.0136
611 ARTHRALGIA 5674 0.0136
612 BLOOD PRESSURE FLUCTUATION 327 0.0136
613 DIZZINESS POSTURAL 132 0.0136
614 TOOTH FRACTURE 150 0.0136
615 GINGIVAL BLEEDING 185 0.0135
616 HEPATOMEGALY 133 0.0135
617 HEPATIC FAILURE 407 0.0135
618 SQUAMOUS CELL CARCINOMA 127 0.0135
619 PHOTOSENSITIVITY REACTION 222 0.0134
620 WRIST FRACTURE 161 0.0134
621 LEUKOCYTOSIS 243 0.0134
622 RED BLOOD CELL COUNT DECREASED 383 0.0134
623 LEUKOPENIA 669 0.0134
624 NASOPHARYNGITIS 2463 0.0133
625 SKIN ULCER 345 0.0133
626 HALLUCINATION, VISUAL 281 0.0133
627 CHOLECYSTECTOMY 152 0.0133
628 ASTHENIA 4991 0.0133
629 GENERALISED OEDEMA 164 0.0132
630 CEREBRAL HAEMORRHAGE 474 0.0132
631 MASS 185 0.0132
632 HYPOTENSION 2650 0.0132
633 GASTRIC HAEMORRHAGE 152 0.0132
634 PRODUCTIVE COUGH 629 0.0132
635 BLOOD PRESSURE DECREASED 874 0.0131
636 IMPAIRED QUALITY OF LIFE 189 0.0131
637 VIRAL INFECTION 437 0.0131
638 LACTIC ACIDOSIS 425 0.0131
639 PAIN IN JAW 371 0.0131
640 HAEMATOCHEZIA 722 0.0131
641 BASAL CELL CARCINOMA 204 0.0131
642 SPLENOMEGALY 153 0.0130
643 UNRESPONSIVE TO STIMULI 337 0.0130
644 RASH PRURITIC 704 0.0130
645 PLATELET COUNT DECREASED 1384 0.0130
646 RESPIRATORY DISTRESS 358 0.0130
647 PHARYNGEAL SWELLING 126 0.0129
648 COVID-19 PNEUMONIA 152 0.0129
649 GROIN PAIN 113 0.0129
650 APHASIA 388 0.0128
651 SEROTONIN SYNDROME 246 0.0128
652 PALLOR 346 0.0127
653 DIZZINESS 6325 0.0127
654 INSOMNIA 3377 0.0127
655 NEUTROPENIA 1722 0.0127
656 ENCEPHALOPATHY 311 0.0127
657 DEPRESSED MOOD 667 0.0126
658 PARKINSONISM 123 0.0126
659 BIPOLAR DISORDER 137 0.0126
660 WEIGHT DECREASED 3513 0.0126
661 DRUG LEVEL INCREASED 208 0.0126
662 JOINT INJURY 268 0.0125
663 DISORIENTATION 497 0.0125
664 CHEST DISCOMFORT 1284 0.0125
665 BODY HEIGHT DECREASED 134 0.0125
666 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 601 0.0125
667 TREATMENT FAILURE 1032 0.0124
668 VERTIGO 757 0.0124
669 BALANCE DISORDER 1071 0.0124
670 RASH GENERALISED 320 0.0123
671 SKIN LESION 338 0.0123
672 URINARY TRACT INFECTION 2097 0.0123
673 MENTAL STATUS CHANGES 341 0.0123
674 SOMNOLENCE 2464 0.0122
675 FEELING HOT 750 0.0122
676 FLUID RETENTION 622 0.0122
677 PLATELET COUNT INCREASED 159 0.0122
678 PETECHIAE 127 0.0122
679 WEIGHT INCREASED 2717 0.0121
680 PHARMACEUTICAL PRODUCT COMPLAINT 313 0.0120
681 MUSCLE RIGIDITY 144 0.0120
682 LUNG INFECTION 187 0.0120
683 LIGAMENT SPRAIN 119 0.0120
684 NODULE 157 0.0120
685 TOOTHACHE 217 0.0120
686 DIARRHOEA HAEMORRHAGIC 112 0.0120
687 CYTOMEGALOVIRUS INFECTION 199 0.0120
688 CARDIO-RESPIRATORY ARREST 499 0.0119
689 INTENTIONAL PRODUCT MISUSE 1043 0.0119
690 MYALGIA 2024 0.0119
691 FLATULENCE 675 0.0119
692 RASH 5165 0.0118
693 NAUSEA 9373 0.0118
694 MYOCARDIAL INFARCTION 2055 0.0118
695 EYE HAEMORRHAGE 157 0.0118
696 COELIAC DISEASE 115 0.0117
697 BLOOD IRON DECREASED 139 0.0117
698 OVARIAN CYST 117 0.0117
699 PRURITUS GENERALISED 253 0.0117
700 RESPIRATORY TRACT INFECTION 304 0.0117
701 CANDIDA INFECTION 197 0.0117
702 PARANOIA 201 0.0116
703 ORAL DISCOMFORT 162 0.0116
704 PAIN IN EXTREMITY 3428 0.0116
705 PULMONARY OEDEMA 520 0.0116
706 DRUG TOXICITY 158 0.0116
707 RASH ERYTHEMATOUS 554 0.0116
708 DYSGEUSIA 859 0.0116
709 LIMB INJURY 313 0.0115
710 FALL 3833 0.0115
711 ABDOMINAL PAIN LOWER 291 0.0115
712 HEART RATE IRREGULAR 260 0.0115
713 DEVICE RELATED INFECTION 177 0.0115
714 HERNIA 222 0.0115
715 CARDIAC ARREST 945 0.0114
716 MYOCARDITIS 131 0.0114
717 SKIN INFECTION 128 0.0114
718 PAIN 6988 0.0114
719 HEAD INJURY 360 0.0114
720 HEADACHE 7108 0.0113
721 THINKING ABNORMAL 211 0.0113
722 LOCAL SWELLING 197 0.0113
723 COLON CANCER 168 0.0113
724 COUGH 3160 0.0113
725 HYPERTHYROIDISM 163 0.0112
726 STATUS EPILEPTICUS 127 0.0112
727 PNEUMOTHORAX 178 0.0112
728 VISUAL IMPAIRMENT 1388 0.0112
729 IMPAIRED WORK ABILITY 239 0.0112
730 INTESTINAL OBSTRUCTION 421 0.0112
731 PANIC ATTACK 405 0.0111
732 CONVULSION 634 0.0111
733 DIABETIC KETOACIDOSIS 266 0.0111
734 BRONCHOSPASM 158 0.0111
735 LOSS OF CONSCIOUSNESS 1418 0.0111
736 EPISTAXIS 827 0.0110
737 GASTRIC DISORDER 379 0.0110
738 FEMUR FRACTURE 342 0.0110
739 TREMOR 1832 0.0110
740 ADVERSE DRUG REACTION 991 0.0110
741 HEART RATE DECREASED 387 0.0110
742 ANHEDONIA 288 0.0109
743 DYSKINESIA 443 0.0109
744 PRURITUS 4175 0.0109
745 THROAT TIGHTNESS 293 0.0108
746 SHOCK 249 0.0108
747 THROAT IRRITATION 485 0.0108
748 PHOTOPHOBIA 203 0.0108
749 POST PROCEDURAL COMPLICATION 207 0.0108
750 ABSCESS 171 0.0107
751 GENERALISED TONIC-CLONIC SEIZURE 176 0.0106
752 HAEMORRHAGE INTRACRANIAL 159 0.0106
753 MUSCLE TIGHTNESS 172 0.0106
754 INTESTINAL PERFORATION 119 0.0106
755 WHITE BLOOD CELL COUNT DECREASED 1149 0.0106
756 GASTROENTERITIS VIRAL 191 0.0106
757 GLAUCOMA 203 0.0105
758 AGITATION 774 0.0105
759 TENDON RUPTURE 130 0.0105
760 THIRST 188 0.0105
761 PERIPHERAL COLDNESS 144 0.0105
762 DEMENTIA 293 0.0105
763 POST PROCEDURAL HAEMORRHAGE 121 0.0104
764 FATIGUE 8086 0.0104
765 BLOOD URINE PRESENT 197 0.0104
766 ERECTILE DYSFUNCTION 265 0.0103
767 SKIN LACERATION 112 0.0103
768 SCAR 176 0.0103
769 GAIT DISTURBANCE 1966 0.0103
770 RETCHING 219 0.0103
771 EATING DISORDER 218 0.0102
772 FEEDING DISORDER 207 0.0102
773 ABNORMAL DREAMS 281 0.0102
774 ECZEMA 532 0.0102
775 OROPHARYNGEAL PAIN 941 0.0102
776 ANAPHYLACTIC SHOCK 262 0.0102
777 ABASIA 251 0.0101
778 CATARACT 604 0.0101
779 ARRHYTHMIA 480 0.0101
780 CONJUNCTIVITIS 188 0.0101
781 CYTOKINE RELEASE SYNDROME 202 0.0101
782 SCHIZOPHRENIA 122 0.0100
783 EYE INFECTION 112 0.0099
784 DELUSION 154 0.0099
785 ACTIVITIES OF DAILY LIVING IMPAIRED 196 0.0099
786 POOR QUALITY SLEEP 212 0.0098
787 HALLUCINATION, AUDITORY 156 0.0098
788 SPINAL FRACTURE 196 0.0098
789 HYPOKINESIA 141 0.0097
790 DERMATITIS ALLERGIC 122 0.0097
791 CHOKING 189 0.0097
792 HYPOAESTHESIA ORAL 146 0.0097
793 ACUTE HEPATIC FAILURE 132 0.0096
794 MUSCULOSKELETAL DISCOMFORT 166 0.0096
795 LYMPHADENOPATHY 341 0.0096
796 FLUID OVERLOAD 140 0.0096
797 CYANOSIS 151 0.0096
798 ORAL HERPES 187 0.0096
799 TOOTH INFECTION 126 0.0095
800 SINUS CONGESTION 129 0.0095
801 CYSTITIS 303 0.0095
802 ACCIDENTAL OVERDOSE 347 0.0095
803 BURNING SENSATION 664 0.0095
804 BONE PAIN 551 0.0094
805 RASH MACULAR 328 0.0094
806 DRY EYE 468 0.0094
807 RESPIRATORY ARREST 258 0.0094
808 PRODUCT USE IN UNAPPROVED INDICATION 2317 0.0093
809 LABORATORY TEST ABNORMAL 275 0.0093
810 CEREBROVASCULAR ACCIDENT 1571 0.0093
811 PRODUCT USE ISSUE 1740 0.0092
812 UPPER LIMB FRACTURE 184 0.0092
813 HERPES ZOSTER 530 0.0092
814 SENSORY DISTURBANCE 148 0.0092
815 DYSSTASIA 269 0.0092
816 CHILLS 1076 0.0092
817 FEELING COLD 255 0.0092
818 SINUS DISORDER 181 0.0091
819 MENTAL DISORDER 396 0.0091
820 IMMUNODEFICIENCY 135 0.0090
821 PULMONARY ARTERIAL HYPERTENSION 131 0.0090
822 FEAR 243 0.0090
823 DERMATITIS 189 0.0090
824 BLOOD PRESSURE INCREASED 1378 0.0090
825 NASAL CONGESTION 529 0.0090
826 METASTASES TO LIVER 158 0.0090
827 THROMBOSIS 720 0.0089
828 FEELING ABNORMAL 2143 0.0089
829 SPEECH DISORDER 467 0.0089
830 SKIN DISORDER 297 0.0089
831 LOCALISED INFECTION 215 0.0089
832 TOOTH DISORDER 197 0.0089
833 EXPOSURE DURING PREGNANCY 548 0.0088
834 RHINORRHOEA 562 0.0087
835 ERYTHEMA 1782 0.0087
836 PSYCHOTIC DISORDER 256 0.0087
837 DYSTONIA 168 0.0087
838 THERAPEUTIC RESPONSE DECREASED 525 0.0087
839 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 201 0.0086
840 MIDDLE INSOMNIA 161 0.0086
841 BRAIN FOG 134 0.0085
842 FUNGAL INFECTION 283 0.0085
843 VISION BLURRED 1164 0.0085
844 PELVIC PAIN 154 0.0085
845 BLOOD GLUCOSE DECREASED 407 0.0085
846 LACRIMATION INCREASED 256 0.0085
847 ADVERSE EVENT 780 0.0085
848 APHONIA 118 0.0084
849 AGGRESSION 423 0.0084
850 OFF LABEL USE 7398 0.0084
851 INTENTIONAL DRUG MISUSE 176 0.0084
852 LYMPHOMA 130 0.0084
853 METASTASES TO BONE 138 0.0084
854 PERITONITIS 174 0.0084
855 EXTRAPYRAMIDAL DISORDER 208 0.0084
856 NERVOUSNESS 436 0.0083
857 COMA 396 0.0083
858 SUICIDAL IDEATION 761 0.0083
859 HYPERSOMNIA 238 0.0083
860 FLUSHING 843 0.0083
861 MANIA 136 0.0083
862 DRUG PRESCRIBING ERROR 158 0.0082
863 NERVOUS SYSTEM DISORDER 255 0.0082
864 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 448 0.0082
865 MALIGNANT NEOPLASM PROGRESSION 831 0.0081
866 CARDIOVASCULAR DISORDER 204 0.0080
867 PARALYSIS 115 0.0080
868 SEIZURE 922 0.0080
869 BLOOD GLUCOSE INCREASED 1499 0.0079
870 SEASONAL ALLERGY 112 0.0079
871 MYELODYSPLASTIC SYNDROME 114 0.0079
872 DEAFNESS 205 0.0078
873 OSTEONECROSIS 257 0.0078
874 EYE SWELLING 290 0.0078
875 MOVEMENT DISORDER 250 0.0078
876 EMOTIONAL DISORDER 240 0.0078
877 MOOD SWINGS 247 0.0077
878 BLOOD COUNT ABNORMAL 117 0.0077
879 FRACTURE 146 0.0077
880 HAEMORRHAGE 806 0.0077
881 EYE PAIN 434 0.0077
882 HIP FRACTURE 247 0.0077
883 TREATMENT NONCOMPLIANCE 420 0.0077
884 ABNORMAL BEHAVIOUR 304 0.0077
885 COVID-19 1339 0.0076
886 SEDATION 198 0.0076
887 INFLUENZA LIKE ILLNESS 621 0.0075
888 AGEUSIA 188 0.0075
889 MENTAL IMPAIRMENT 182 0.0075
890 PSYCHOMOTOR HYPERACTIVITY 124 0.0075
891 GLYCOSYLATED HAEMOGLOBIN INCREASED 187 0.0074
892 THYROID DISORDER 114 0.0074
893 SKIN DISCOLOURATION 339 0.0074
894 VISUAL ACUITY REDUCED 244 0.0073
895 TARDIVE DYSKINESIA 206 0.0073
896 RESTLESSNESS 266 0.0073
897 ANGER 245 0.0072
898 HOT FLUSH 546 0.0072
899 WRONG TECHNIQUE IN DRUG USAGE PROCESS 260 0.0071
900 BONE DENSITY DECREASED 224 0.0071
901 CARDIAC DISORDER 668 0.0071
902 MOOD ALTERED 194 0.0071
903 FEELING JITTERY 134 0.0070
904 HEAD DISCOMFORT 124 0.0070
905 PLASMA CELL MYELOMA 269 0.0069
906 DISEASE PROGRESSION 811 0.0068
907 DRY SKIN 912 0.0068
908 LIMB DISCOMFORT 211 0.0068
909 THERAPEUTIC RESPONSE UNEXPECTED 301 0.0067
910 BLOOD PRESSURE ABNORMAL 131 0.0066
911 INFLUENZA 733 0.0066
912 HEPATOTOXICITY 146 0.0066
913 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 466 0.0065
914 PRODUCT ADMINISTRATION ERROR 131 0.0065
915 IRRITABILITY 389 0.0065
916 DISEASE RECURRENCE 306 0.0064
917 LUNG NEOPLASM MALIGNANT 264 0.0064
918 MULTIPLE SCLEROSIS 307 0.0064
919 CRYING 233 0.0064
920 EYE DISORDER 210 0.0064
921 PRODUCT SUBSTITUTION ISSUE 364 0.0063
922 TOOTH LOSS 130 0.0063
923 INCREASED APPETITE 119 0.0062
924 PSORIASIS 812 0.0062
925 SNEEZING 137 0.0061
926 EMOTIONAL DISTRESS 736 0.0061
927 SKIN FISSURES 118 0.0060
928 INTENTIONAL SELF-INJURY 121 0.0060
929 WITHDRAWAL SYNDROME 243 0.0058
930 DRUG DEPENDENCE 919 0.0057
931 PREMATURE BABY 171 0.0057
932 DRUG EFFECT DECREASED 304 0.0056
933 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 392 0.0055
934 UNEVALUABLE EVENT 412 0.0054
935 DEATH 4638 0.0054
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 968 0.0054
937 OVERDOSE 1158 0.0054
938 SKIN EXFOLIATION 449 0.0053
939 TOXICITY TO VARIOUS AGENTS 889 0.0053
940 OCULAR HYPERAEMIA 248 0.0052
941 UNDERDOSE 375 0.0051
942 DRUG INEFFECTIVE 6767 0.0051
943 PRODUCT PRESCRIBING ERROR 118 0.0049
944 DRUG ADMINISTRATION ERROR 152 0.0049
945 ILLNESS 502 0.0049
946 PROCEDURAL PAIN 135 0.0049
947 PRODUCT QUALITY ISSUE 644 0.0047
948 NEOPLASM PROGRESSION 164 0.0047
949 INTENTIONAL OVERDOSE 298 0.0046
950 PANCREATIC CARCINOMA 134 0.0046
951 HOSPITALISATION 692 0.0045
952 SURGERY 251 0.0043
953 VAGINAL HAEMORRHAGE 179 0.0041
954 DRUG EXPOSURE DURING PREGNANCY 138 0.0041
955 EYE IRRITATION 233 0.0040
956 DRUG WITHDRAWAL SYNDROME 347 0.0040
957 DRUG DOSE OMISSION 652 0.0039
958 NEOPLASM MALIGNANT 262 0.0039
959 INJECTION SITE RASH 119 0.0039
960 SUICIDE ATTEMPT 232 0.0038
961 GYNAECOMASTIA 118 0.0038
962 INCORRECT DOSE ADMINISTERED 862 0.0038
963 INJECTION SITE ERYTHEMA 464 0.0037
964 INJECTION SITE REACTION 252 0.0037
965 INJECTION SITE HAEMORRHAGE 279 0.0035
966 HYPOACUSIS 150 0.0035
967 INJECTION SITE BRUISING 275 0.0034
968 RENAL CANCER 164 0.0034
969 INJECTION SITE MASS 127 0.0034
970 DRUG ABUSE 281 0.0034
971 EXPIRED PRODUCT ADMINISTERED 112 0.0034
972 INJECTION SITE PRURITUS 210 0.0031
973 DRUG EFFECT INCOMPLETE 112 0.0031
974 MYELOSUPPRESSION 111 0.0031
975 SKIN IRRITATION 132 0.0029
976 PRODUCT DOSE OMISSION ISSUE 844 0.0029
977 THERAPY CESSATION 147 0.0029
978 EXTRA DOSE ADMINISTERED 113 0.0028
979 INJECTION SITE SWELLING 211 0.0028
980 INJECTION SITE PAIN 844 0.0027
981 MULTIPLE SCLEROSIS RELAPSE 183 0.0027
982 NO ADVERSE EVENT 473 0.0026
983 PROSTATE CANCER 209 0.0026
984 BREAST CANCER 240 0.0026
985 PRODUCT DOSE OMISSION 166 0.0025
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 509 0.0025
987 FOETAL EXPOSURE DURING PREGNANCY 189 0.0023
988 ACNE 172 0.0023
989 SKIN BURNING SENSATION 162 0.0023
990 THERAPY INTERRUPTED 139 0.0019
991 DEVICE MALFUNCTION 135 0.0019
992 DEVICE ISSUE 172 0.0019
993 COMPLETED SUICIDE 144 0.0017